Hepatitis C virus is now known to be the causative agent for at least 90% of non-A, non-B hepatitis cases. In the few years since its characterization, much has been learned about this virus and the scope of its disease. It now appears that close to 100% of infections may become chronic, with delayed but potentially devastating consequences. The treatment options for hepatitis C remain limited and less than satisfactory. A vaccine seems to be a distant goal, but other strategies for treatment may be closer. For now, the best option remains prevention. (Arch Surg. 1996;131:18-23)
Colquhoun SD. Hepatitis C: A Clinical Update. Arch Surg. 1996;131(1):18–23. doi:10.1001/archsurg.1996.01430130020004
Monkeypox Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.